{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:27:35Z","timestamp":1778887655777,"version":"3.51.4"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"8","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI 111341"],"award-info":[{"award-number":["R01 AI 111341"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01\u2009HD 080670"],"award-info":[{"award-number":["R01\u2009HD 080670"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_165782"],"award-info":[{"award-number":["310030_165782"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000199","name":"U.S. Department of Agriculture","doi-asserted-by":"publisher","award":["2014\u201367015-22106"],"award-info":[{"award-number":["2014\u201367015-22106"]}],"id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1093\/jac\/dkx134","type":"journal-article","created":{"date-parts":[[2017,4,16]],"date-time":"2017-04-16T19:06:37Z","timestamp":1492369597000},"page":"2334-2341","source":"Crossref","is-referenced-by-count":45,"title":["Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis"],"prefix":"10.1093","volume":"72","author":[{"given":"Joachim","family":"M\u00fcller","sequence":"first","affiliation":[{"name":"Institute of Parasitology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, L\u00e4nggass-Strasse 122, CH-3012 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Aguado-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Institute of Parasitology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, L\u00e4nggass-Strasse 122, CH-3012 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis-Miguel","family":"Ortega-Mora","sequence":"additional","affiliation":[{"name":"SALUVET, Animal Health Department, Faculty of Veterinary Sciences, Complutense University of Madrid, Ciudad Universitaria s\/n, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Moreno-Gonzalo","sequence":"additional","affiliation":[{"name":"SALUVET, Animal Health Department, Faculty of Veterinary Sciences, Complutense University of Madrid, Ciudad Universitaria s\/n, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Ferre","sequence":"additional","affiliation":[{"name":"SALUVET, Animal Health Department, Faculty of Veterinary Sciences, Complutense University of Madrid, Ciudad Universitaria s\/n, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Hulverson","sequence":"additional","affiliation":[{"name":"Center for Emerging and Reemerging Infectious Diseases (CERID), Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Choi","sequence":"additional","affiliation":[{"name":"Center for Emerging and Reemerging Infectious Diseases (CERID), Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly C.","family":"McCloskey","sequence":"additional","affiliation":[{"name":"Center for Emerging and Reemerging Infectious Diseases (CERID), Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn K.","family":"Barrett","sequence":"additional","affiliation":[{"name":"Center for Emerging and Reemerging Infectious Diseases (CERID), Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dustin J.","family":"Maly","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Washington, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayode K.","family":"Ojo","sequence":"additional","affiliation":[{"name":"Center for Emerging and Reemerging Infectious Diseases (CERID), Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wes","family":"Van Voorhis","sequence":"additional","affiliation":[{"name":"Center for Emerging and Reemerging Infectious Diseases (CERID), Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hemphill","sequence":"additional","affiliation":[{"name":"Institute of Parasitology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, L\u00e4nggass-Strasse 122, CH-3012 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,5,9]]},"reference":[{"key":"key\n\t\t\t\t20180328132914_dkx134-B1","volume-title":"Toxoplasmosis of Animals and Humans","author":"Dubey","year":"2010"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B2","doi-asserted-by":"crossref","first-page":"589295.","DOI":"10.1155\/2012\/589295","article-title":"Toxoplasma on the brain: understanding host-pathogen interactions in chronic CNS infection","volume":"2012","author":"Kamerkar","year":"2012","journal-title":"J Parasitol Res"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/B978-0-12-800182-0.00003-9","article-title":"Reevaluating the evidence for Toxoplasma gondii-induced behavioural changes in rodents","volume":"85","author":"Worth","year":"2014","journal-title":"Adv Parasitol"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B4","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00127-014-0820-5","article-title":"The association of Toxoplasma gondii infection with neurocognitive deficits in a population-based analysis","volume":"49","author":"Pearce","year":"2014","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1586\/14787210.2015.1051033","article-title":"Schizophrenia and Toxoplasma gondii: an undervalued association?","volume":"13","author":"Flegr","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1055\/s-0041-111821","article-title":"Ocular toxoplasmosis: an update","volume":"233","author":"Garweg","year":"2016","journal-title":"Klin Monbl Augenheilkd"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4269\/ajtmh.1953.2.429","article-title":"The present status of the chemotherapy of toxoplasmosis","volume":"2","author":"Eyles","year":"1953","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B8","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/AAC.02009-15","article-title":"Clinically available medicines demonstrating anti-Toxoplasma activity","volume":"59","author":"Neville","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B9","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1517\/14656566.2.8.1269","article-title":"Options for the pharmacotherapy of toxoplasmosis during pregnancy","volume":"2","author":"Peyron","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B10","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511527005","volume-title":"Toxoplasmosis: A Comprehensive Clinical Guide","author":"Joynson","year":"2001"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/B978-0-12-407704-1.00007-5","article-title":"New approaches for the identification of drug targets in protozoan parasites","volume":"301","author":"M\u00fcller","year":"2013","journal-title":"Int Rev Cell Mol Biol"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/17460441.2016.1195945","article-title":"Drug target identification in protozoan parasites","volume":"11","author":"M\u00fcller","year":"2016","journal-title":"Expert Opin Drug Discov"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.pt.2016.04.013","article-title":"The past, present, and future of genetic manipulation in Toxoplasma gondii","volume":"32","author":"Wang","year":"2016","journal-title":"Trends Parasitol"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B14","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s12639-014-0589-1","article-title":"Pathobiology of human RH strain induced experimental toxoplasmosis in murine model","volume":"40","author":"Sudan","year":"2016","journal-title":"J Parasit Dis"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.vetpar.2016.04.024","article-title":"Vertical transmission and fetal damage in animal models of congenital toxoplasmosis: a systematic review","volume":"223","author":"Vargas-Villavicencio","year":"2016","journal-title":"Vet Parasitol"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B16","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2460\/ajvr.1990.51.08.1295","article-title":"Diagnosis of transplacentally induced toxoplasmosis in pigs","volume":"51","author":"Dubey","year":"1990","journal-title":"Am J Vet Res"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/030098589902700605","article-title":"Lesions in fetal pigs with transplacentally-induced toxoplasmosis","volume":"27","author":"Dubey","year":"1990","journal-title":"Vet Pathol"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B18","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1128\/IAI.59.9.3301-3302.1991","article-title":"Rat model of congenital toxoplasmosis","volume":"59","author":"Dubey","year":"1991","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S003118209700231X","article-title":"Vertical transmission of Toxoplasma gondii from chronically infected house (Mus musculus) and field (Apodemus sylvaticus) mice determined by polymerase chain reaction","volume":"116","author":"Owen","year":"1998","journal-title":"Parasitology"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.rvsc.2016.06.010","article-title":"Infection of mice with oocysts of Toxoplasma gondii by oral route showed differences of virulence from Brazilian RFLP genotypes BrI and BrIII","volume":"107","author":"Chiebao","year":"2016","journal-title":"Res Vet Sci"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/S0031182000049003","article-title":"Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity","volume":"90","author":"Hudson","year":"1985","journal-title":"Parasitology"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B22","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2460\/ajvr.1989.50.05.782","article-title":"Evaluations of buparvaquone as a treatment for equine babesiosis (Babesia equi)","volume":"50","author":"Zaugg","year":"1989","journal-title":"Am J Vet Res"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0034-5288(18)31765-X","article-title":"Antitheilerial activity of BW720C (buparvaquone): a comparison with parvaquone","volume":"39","author":"McHardy","year":"1985","journal-title":"Res Vet Sci"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jac\/30.6.827","article-title":"The activity of hydroxynaphthoquinones against Leishmania donovani","volume":"30","author":"Croft","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1550-7408.2006.00127.x","article-title":"Ubiquinone synthesis and its regulation in Pneumocystis carinii","volume":"53","author":"Kaneshiro","year":"2006","journal-title":"J Eukaryot Microbiol"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B26","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0006-2952(92)90213-3","article-title":"Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80)","volume":"43","author":"Fry","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijpddr.2015.02.001","article-title":"Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice","volume":"5","author":"M\u00fcller","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B28","doi-asserted-by":"crossref","first-page":"32.","DOI":"10.1186\/s13567-016-0317-1","article-title":"Repurposing of antiparasitic drugs: the hydroxy-naphthoquinone buparvaquone inhibits vertical transmission in the pregnant neosporosis mouse model","volume":"47","author":"M\u00fcller","year":"2016","journal-title":"Vet Res"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B29","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/infdis\/jit327","article-title":"A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis","volume":"208","author":"Castellanos-Gonzalez","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B30","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1021\/jm4001314","article-title":"Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by Toxoplasma gondii","volume":"56","author":"Lourido","year":"2013","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B31","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1128\/AAC.01823-13","article-title":"Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection","volume":"58","author":"Doggett","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B32","doi-asserted-by":"crossref","first-page":"e92929","DOI":"10.1371\/journal.pone.0092929","article-title":"Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapy","volume":"9","author":"Ojo","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B33","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1128\/AAC.01236-15","article-title":"In vitro and in vivo effects of the bumped kinase inhibitor 1294 in the related cyst-forming apicomplexans Toxoplasma gondii and Neospora caninum","volume":"59","author":"Winzer","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B34","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1021\/jm201713h","article-title":"Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-Toxoplasma activity","volume":"55","author":"Johnson","year":"2012","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mimet.2011.10.010","article-title":"Methods to produce and safely work with large numbers of Toxoplasma gondii oocysts and bradyzoite cysts","volume":"88","author":"Fritz","year":"2012","journal-title":"J Microbiol Methods"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1645\/GE-1063R.1","article-title":"Chemical inactivation of Toxoplasma gondii oocysts in water","volume":"93","author":"Wainwright","year":"2007","journal-title":"J Parasitol"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vetpar.2015.05.021","article-title":"Dose-dependent effects of experimental infection with the virulent Neospora caninum Nc-Spain7 isolate in a pregnant mouse model","volume":"211","author":"Arranz-Solis","year":"2015","journal-title":"Vet Parasitol"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B38","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/JCM.38.8.2929-2932.2000","article-title":"Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes","volume":"38","author":"Costa","year":"2000","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1645\/GE-379R","article-title":"Differential effects of interferon-gamma and tumor necrosis factor-alpha on Toxoplasma gondii proliferation in organotypic rat brain slice cultures","volume":"91","author":"Scheidegger","year":"2005","journal-title":"J Parasitol"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B40","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ijpara.2009.04.006","article-title":"Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites","volume":"39","author":"Debache","year":"2009","journal-title":"Int J Parasitol"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B41","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijpara.2008.04.001","article-title":"Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites","volume":"38","author":"Debache","year":"2008","journal-title":"Int J Parasitol"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B42","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1128\/IAI.72.1.576-583.2004","article-title":"In vitro induction of Neospora caninum bradyzoites in Vero cells reveals differential antigen expression, localization, and host-cell recognition of tachyzoites and bradyzoites","volume":"72","author":"Vonlaufen","year":"2004","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B43","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2012"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijantimicag.2015.02.020","article-title":"In vitro effects of new artemisinin derivatives in Neospora caninum-infected human fibroblasts","volume":"46","author":"M\u00fcller","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpddr.2014.09.003","article-title":"A quantitative reverse-transcriptase PCR assay for the assessment of drug activities against intracellular Theileria annulata schizonts","volume":"4","author":"Hostettler","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B46","first-page":"87","article-title":"Parvaquone and buparvaquone: HPLC analysis and comparative pharmacokinetics in cattle","volume":"45","author":"Kinabo","year":"1988","journal-title":"Acta Trop"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/0975-7406.124309","article-title":"Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theileriosis","volume":"6","author":"Soni","year":"2014","journal-title":"J Pharm Bioallied Sci"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.exppara.2012.01.010","article-title":"Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi","volume":"130","author":"Reimao","year":"2012","journal-title":"Exp Parasitol"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B49","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1021\/jm030868a","article-title":"Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone","volume":"47","author":"Mantyla","year":"2004","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B50","doi-asserted-by":"crossref","first-page":"e02324\u201316","DOI":"10.1128\/AAC.02324-16","article-title":"Two novel calcium-dependent kinase 1-inhibitors interfere with vertical transmission in mice infected with Neospora caninum tachyzoites","volume":"61","author":"M\u00fcller","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328132914_dkx134-B51","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1128\/IAI.66.4.1554-1560.1998","article-title":"Antigen-specific CD8+ T cells protect against lethal toxoplasmosis in mice infected with Neospora caninum","volume":"66","author":"Kasper","year":"1998","journal-title":"Infect Immun"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/8\/2334\/24332280\/dkx134.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T22:32:47Z","timestamp":1750199567000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/72\/8\/2334\/3806899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,9]]},"references-count":51,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,5,9]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx134","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,5,9]]}}}